Karolinska Development - Interim report January - March, invitation to conference call Friday, May 10

STOCKHOLM – May 7, 2013. Karolinska Development will publish its Interim report
for January – March 2013 on Friday, May 10, 2013. The company will also host a
conference call and an on-line presentation on the same day at 14.00 CET.
Please dial in at the following number a few minutes before the start of the
conference call:

  · From Sweden: +46 (0)8 506 307 79
  · From the US: +1 866 682 8490
  · From the UK: +44 (0) 1452 555 131

The presentation will also be webcasted and can be accessed from the following
web address:
http://storm.zoomvisionmamato.com/player/karolinska_development/objects/143ch80p
/ 


Host: Torbjörn Bjerke, CEO.

For further information, please contact:
Benjamin Nordin, IRO, Karolinska Development AB
Phone: +46 (0)73 093 60 80, e-mail: benjamin.nordin@karolinskadevelopment.com

TO THE EDITORS

About Karolinska Development AB
Karolinska Development aims to create value for patients, researchers, and
investors by developing innovations from world class science into products that
can be sold or out-licensed with high returns. The business model is to: SELECT
the most commercially attractive medical innovations; DEVELOP innovations to the
stage where the greatest return on investment can be achieved; and COMMERCIALIZE
the innovations through the sale of companies or out-licensing of products. An
exclusive deal flow agreement with Karolinska Institutet Innovations AB, along
with other cooperation agreements with leading universities, delivers a
continuous flow of innovations. Today, the portfolio consists of 36 projects, of
which 15 are in clinical development. For more information, please visit
www.karolinskadevelopment.com.

Karolinska Development is listed on NASDAQ OMX. Karolinska Development may be
required to disclose the information provided herein pursuant to the Securities
Markets Act.